At a glance

What is oligopeptide-1?

Oligopeptide-1, often labeled sh-oligopeptide-1, is the cosmetic ingredient name for epidermal growth factor, a natural human protein of 53 amino acids. The "sh-" prefix means "synthetic human," indicating it is produced by recombinant technology in microbes, yeast, or plants rather than extracted from people. It is a true growth-factor protein, larger than most skincare peptides, and it is a cosmetic ingredient, not a drug.

How does it work?

Laboratory studies show epidermal growth factor works by switching on a cellular growth signal. It binds to the epidermal growth factor receptor on skin cells, which prompts keratinocytes and fibroblasts to multiply, migrate, and renew, the same cascade the body uses during wound healing. In the process, it supports production of collagen, elastin, and other matrix components that influence how firm and smooth skin looks.

One genuine caveat belongs in any honest description: Epidermal growth factor is a relatively large protein, and how much of it can pass through intact outer skin is debated, which is why delivery is a recognized challenge for these products. In finished cosmetics, the goal is described in appearance terms, the look of renewed, smoother, firmer skin.

Is it FDA-approved?

No, and it does not need to be. The FDA does not pre-approve cosmetic ingredients. A cosmetic may describe effects on the appearance of skin, while a claim to heal wounds or change the body's structure would make a product a drug. Oligopeptide-1 is used as a cosmetic ingredient, for the appearance of the skin.

What is it used for?

Oligopeptide-1 is used in "regenerating" or "repair" serums and in post-procedure skincare. The appearance goals are the look of fine lines and improved texture, firmer and more elastic-looking skin, and support for recovery and comfort after cosmetic procedures. It is often combined with other actives.

What does the research show?

Several small human studies point in a positive direction, with important limits. According to PubMed, a small pilot randomized trial¹ comparing a recombinant EGF (oligopeptide-1) serum with another EGF serum found investigator-rated improvements in texture and firmness, though wrinkle change was minimal and the study was small and short. Other work tests EGF inside multi-component regimens², where its individual effect cannot be isolated. There is no large independent trial or meta-analysis supporting standalone topical EGF for wrinkles, so the evidence is suggestive but not robust.

What are the side effects?

Epidermal growth factor products are reported as well tolerated in the small studies available. Because it is a protein that drives cell growth, some caution is reasonable when using it on compromised skin or for people with a personal history of skin cancer; cosmetic topical studies have not shown adverse growth effects, but the data are limited. A patch test is sensible for sensitive skin.

More for skin & aging